» Authors » May Ahmed Shawki

May Ahmed Shawki

Explore the profile of May Ahmed Shawki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 50
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Halawa N, Elsaid T, Wakeel L, Shawki M
Ther Adv Chronic Dis . 2023 Dec; 14:20406223231214641. PMID: 38107482
Background: Magnesium (Mg) deficiency is closely linked with proteinuria. Objectives: To assess the impact of oral Mg citrate supplementation on the clinical outcome of diabetic nephropathy (DN) patients. Design: This...
2.
Shawki M, Kamel A, Gamal S, Abbassi M, Farid S, Sabry N
J Infect Dev Ctries . 2023 Oct; 17(9):1188-1198. PMID: 37824346
Introduction: Coronavirus disease 2019 (COVID-19) vaccine hesitancy is a major problem. This study aimed to determine the factors associated with COVID-19 vaccine acceptance. Methodology: A cross-sectional survey-based study was conducted...
3.
Shawki M, Sabri N, Ibrahim D, Samady M, Hamza M
Saudi Pharm J . 2022 Jun; 30(8):1101-1106. PMID: 35719834
Background: Clinical pharmacists have a vital role during COVID-19 pandemic in mitigating medication errors, particularly prescribing errors in hospitals. That is owing to the fact that prescribing errors during the...
4.
Ibrahim D, Shawki M, Solayman M, Sabri N
Front Pharmacol . 2022 Apr; 13:825048. PMID: 35370698
Albumin is an expensive non-blood plasma substitutes with limited availability that has been reported to be inappropriately used in healthcare settings. Hence, interventions are recommended to control its misuse. To...
5.
Gharib M, Elbaz W, Darweesh E, Sabri N, Shawki M
Front Pharmacol . 2021 Oct; 12:726490. PMID: 34630103
To evaluate the efficacy and safety of metformin use in rheumatoid arthritis (RA) patients receiving conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs). A prospective, randomized, controlled, single blinded, study was...
6.
Ibrahim D, Shawki M, Solayman M, Sabri N
Int J Clin Pract . 2021 Aug; 75(11):e14731. PMID: 34387008
Aim: To assess impact of pharmacovigilance (PV) educational program on knowledge, attitude and practice (KAP) of healthcare professionals (HCPs). Methods: a prospective study was conducted on HCPs at an Egyptian...
7.
Shawki M, Elsayed N, Mantawy E, Said R
Immunopharmacol Immunotoxicol . 2021 May; 43(4):395-409. PMID: 34057871
A global threat has emerged in 2019 due to the rapid spread of Coronavirus disease (COVID-19). As of January 2021, the number of cases worldwide reached 103 million cases and...
8.
Mohamed A, ELBassiouny M, Elkhodary D, Shawki M, Saad A
Med Oncol . 2021 Feb; 38(3):23. PMID: 33559053
Itraconazole is an oral antifungal that has a been reported to have anticancer effect in non-small cell lung cancer (NSCLC) through inhibition of angiogenesis. The aim is to evaluate the...
9.
Saad A, Ghali R, Shawki M
J Cancer Res Ther . 2017 Jun; 13(2):198-203. PMID: 28643733
Background: The use of cisplatin (Cis) versus carboplatin (Carb) in the treatment of advanced nonsmall cell lung cancer (NSCLC) is controversial. The aim of the study was to compare the...